Results 101 to 110 of about 23,157 (288)

Efficacy and safety of the emedastine patch, a novel transdermal drug delivery system for allergic rhinitis: Phase III, multicenter, randomized, double-blinded, placebo-controlled, parallel-group comparative study in patients with seasonal allergic rhinitis

Allergology International, 2018
Background: The emedastine patch was developed in Japan as the first transdermal drug delivery system of emedastine difumarate for allergic rhinitis.
Kimihiro Okubo, Eiji Uchida, Takaaki Terahara, Katsuhiko Akiyama, Shigeo Kobayashi, Yusuke Tanaka   +5 more
doaj   +1 more source

A comparative study about the impact of sensory stimulation performed by family members and nurses on vital signs of patients at ICU: A randomized clinical trial [PDF]

, 2016
Some studies have shown the effects of sensory stimulation on vital signs of patients at intensive care unit (ICU). However, little knowledge is available about family role compared to the role of nursing staff in this issue and current results are ...
Adineh, Mohammad., Gholami, Mohammad., Heidari Soureshjani, Reza., Toulabi, Tahereh.   +3 more
core  

Multicentre, non-interventional study to assess the profile of patients with uncontrolled rhinitis prescribed a novel formulation of azelastine hydrochloride and fluticasone propionate in a single spray in routine clinical practice in the UK [PDF]

, 2017
OBJECTIVE: The aims of this study were (1) to characterise the type of patient prescribed MP-AzeFlu (Dymista, a novel formulation of azelastine hydrochloride, fluticasone propionate and excipients in a single spray) in real life in the UK and physicians'
Agache, Anolik, Bauchau, Bauchau, Bousquet, Bousquet, Bousquet, Bousquet, Bousquet, Bousquet, Bousquet, Bousquet, Clatworthy, de la Hoz Caballer, Demoly, Dollner, Esteitie, Haahr, Klimek, Klimek, Lamb, Meltzer, Meltzer, Price, Price, Price, Scadding, Scadding, Scadding, Stjarne, Valovirta, Vuurman, Walker   +32 more
core   +2 more sources

At-a-glance - Pollens, climate and allergies: Quebec initiatives

Health Promotion and Chronic Disease Prevention in Canada, 2019
Pollen allergies are a major source of seasonal allergic rhinitis in North America. This type of rhinitis affects 17% of adults in Quebec, a marked increase in the last 30 years. Ragweed (Ambrosia artemisiifolia L.) pollens are responsible for 50% to 90%
Isabelle Demers, Pierre Gosselin
doaj   +1 more source

Combined intranasal treatment for allergic rhinitis: an option for children under 12 years of age [PDF]

Exploration of Asthma & Allergy
Intranasal treatments combining corticosteroids with antihistamines are a safe and effective alternative for treating moderate to severe seasonal allergic rhinitis in children over 12 years of age and adults.
Alberto Vidal, Pedro Cortez
doaj   +1 more source

A Walk in the Park: Influence of Natural Co‐Exposure to Grass Pollen and Fungal Spores on Nasal Mycobiome and Cytokine Responses

Clinical &Experimental Allergy, EarlyView.
Volunteers stayed 3 h indoors and followed 1 h outdoors in a flowering meadow. Nasal mycobiome was analysed and aeroallergen content measured in nasal filters. Airborne fungal spores were quantified and fungal isolates were sequenced. Isolated fungal spores were used for stimulation of nasal epithelial cells.
Annika Eggestein, Denise Rauer, Selina M. Herrmann, Franziska Kolek, Vivien Leier‐Wirtz, Swetlana Urban, Bärbel Foesel, Michael Schloter, Madhumita Bhattacharyya, Ioana Pyrri, Matthias Reiger, Vera Schwierzeck, Claudia Hülpüsch, Claudia Traidl‐Hoffmann, Athanasios Damialis, Stefanie Gilles   +15 more
wiley   +1 more source

Online public concern about allergic rhinitis and its association with COVID-19 and air quality in China: an informative epidemiological study using Baidu index

BMC Public Health
Background Allergic rhinitis is a common health concern that affects quality of life. This study aims to examine the online search trends of allergic rhinitis in China before and after the COVID-19 epidemic and to explore the association between the ...
Yi Yu, Qinzhun Zhang, Xinmeng Yao, Jinghua Wu, Jialu He, Yinan He, Huaqiang Jiang, Dongxin Lu, Chengyin Ye   +8 more
doaj   +1 more source

Gut Microbiome Alterations by Allergen Sensitisation and Symptom Severity in Paediatric Allergic Rhinitis

Allergy, EarlyView.
Kunio Miyake, Daisuke Watanabe, Sanae Otawa, Megumi Kushima, Hideki Yui, Ryoji Shinohara, Daiju Sakurai, Zentaro Yamagata   +7 more
wiley   +1 more source

Effectiveness and Predictors of House Dust Mite Subcutaneous Immunotherapy in Polysensitised Patients With Allergic Rhinitis: A Multicentre Retrospective Study

Clinical &Experimental Allergy, EarlyView.
Single‐allergen dust mite subcutaneous immunotherapy achieved 68.8% perennial symptom response rate in polysensitised allergic rhinitis patients. High mould and dust mite sIgE levels predicted poor allergen immunotherapy response, which indicated allergen‐specific sIgE levels may help guide personalised allergen immunotherapy decisions.
Zhouxian Pan, Shengyang Yao, Lisha Li, Yongshi Yang, Wenchao Guan, Yin Wang, Xiaoshang Lou, Chuanhe Liu, Yanmin Bao, Shijie Zhuang, Li Sha, Ruonan Chai, Rongfei Zhu, Kai Guan   +13 more
wiley   +1 more source

A new therapy (MP29‐02*) effectively treats patients with seasonal allergic rhinitis who suffer most from the bothersome nasal symptom of congestion [PDF]

, 2013
Claus Bachert, David Price, Glenis Scadding, Wytske J. Fokkens, Peter W. Hellings, Ullrich Munzel, Jean Bousquet   +6 more
openalex   +1 more source